A male and female couple in their 60s hugging by the sea
Explore

Non-endoscopic diagnostics for GI care

We are a leading gastrointestinal health company transforming access to digestive health for everyone, everywhere.
Explore
Impact

Earlier matters

Upper GI diseases and cancers affect millions of people globally, every year. With our non-endoscopic diagnostic platform, we are transforming care for digestive diseases by ensuring earlier detection and improving access.

1 in 10

people suffer from upper GI diseases
A photo of the EndoSign cell collection device
EndoSign® is a fast and simple test to protect esophageal health by detecting and monitoring for signs of pre-cancer and other diseases.
Find out more:
Patients
Practitioners
Research

Recent news

View All
31
October 2024
Nursing Times feature: Leicester's capsule sponge nurses expand EndoSign testing to the community
Read more
No items found.
29
July 2024
Gastroenterology Today Feature: How can capsule sponge testing support staff retention and boost endoscopy capacity?
Read more
No items found.
11
April 2024
Cyted Health Appoints Betsy Hanna US President
Read more
No items found.

In partnership with

Cyted is proud to collaborate with a network of esteemed partners and investors who share our vision for innovative healthcare solutions.
A couple in their 60's hugging at home
Get in touch for more information about our early cancer test and data-driven diagnostics.
Get in touch